Axsome Therapeutics to Participate in Investor Conferences in September
Axsome Therapeutics to Participate in Investor Conferences in September
Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York
摩根士丹利第22届全球医疗健康大会将于9月4日在纽约举行
Wells Fargo Healthcare Conference on September 5 in Boston
富国银行医疗健康大会将于9月5日在波士顿举行
Baird 2024 Global Healthcare Conference on September 11 in New York
贝尔德2024年全球医疗健康大会将于9月11日在纽约举行
Cantor Global Healthcare Conference on September 18 in New York
康泰医疗健康大会将于9月18日在纽约举行
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will participate in four investor conferences in September:
Axsome Therapeutics，Inc.（NASDAQ：AXSM）是一家生物制药公司，致力于开发和提供用于中枢神经系统（CNS）疾病治疗的新疗法，将参加9月份的四个投资者会议：
-
Morgan Stanley 22nd Annual Global Healthcare Conference
The Company will present on Wednesday, September 4, 2024 at 4:50 p.m. ET in New York, NY
- 摩根士丹利第22届全球医疗保健大会
该公司将于2024年9月4日下午4:50在纽约进行演讲
-
2024 Wells Fargo Healthcare Conference
The Company will participate in investor meetings on Thursday, September 5, 2024 in Boston, MA
- 2024年富国银行医疗保健会议
该公司将于2024年9月5日在马萨诸塞州波士顿参加投资者会议
-
Baird 2024 Global Healthcare Conference
The Company will present on Wednesday, September 11, 2024 at 8:30 a.m. ET in New York, NY
- 贝尔德2024全球医疗保健大会
该公司将于2024年9月11日上午8:30在纽约进行演讲
-
2024 Cantor Global Healthcare Conference
The Company will present on Wednesday, September 18, 2024 at 9:45 a.m. ET in New York, NY
- 2024年Cantor全球医疗健康大会
公司将于2024年9月18日上午9:45在纽约举行演讲。
Live webcasts of the presentations at the Morgan Stanley and Cantor conferences can be accessed on the Investors page of the Company's website at . Replays of the webcasts will be available for approximately 30 days following each event.
公司在摩根士丹利和康泰会议上的演讲可以在公司网站的投资者页面上访问。演讲的重播将在每个活动后的约30天内提供。
About Axsome Therapeutics
关于axsome therapeutics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. For more information, please visit the Company's website at .
Axsome Therapeutics, Inc.是一家生物制药公司，致力于开发和提供中枢神经系统（CNS）疾病的新疗法，这些疾病的治疗选择有限。通过开发具有新型作用机制的治疗选择，我们正在改变治疗CNS疾病的方法。在axsome，我们致力于开发可以显著改善患者生活并为医生提供新疗法选择的产品。欲了解更多信息，请访问公司网站。
Investors:
Mark Jacobson
Chief Operating Officer
(212) 332-3243
mjacobson@axsome.com
投资者：
马克·雅各布森
首席运营官
(212) 332-3243
mjacobson@axsome.com
Media:
Darren Opland
Director, Corporate Communications
(929) 837-1065
dopland@axsome.com
媒体：
Darren Opland
董事，企业通信
（929）837-1065
dopland@axsome.com